{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:40:23Z","timestamp":1792701623440,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008717","name":"Sylvia and Charles Viertel Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001232","name":"Royal Australasian College of Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008639","name":"Sir Edward 'Weary' Dunlop Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0767-3","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T01:33:45Z","timestamp":1512524025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate"],"prefix":"10.1186","volume":"18","author":[{"given":"Amanda","family":"Leong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Ilhan","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cattram","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Hachem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"MacIsaac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Jerums","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"key":"767_CR1","first-page":"S1","volume":"39","author":"Foundation, N.K","year":"2002","unstructured":"Foundation, N.K. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39:S1\u2013S266.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"767_CR2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/ki.2014.98","volume":"86","author":"RJ MacIsaac","year":"2014","unstructured":"MacIsaac RJ, Ekinci EI, Jerums G. Progressive diabetic nephropathy. How useful is microalbuminuria. Kidney Int. 2014;86(1):50\u20137.","journal-title":"Kidney Int"},{"issue":"2","key":"767_CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/08860228509088195","volume":"9","author":"CE Mogensen","year":"1985","unstructured":"Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebvre P, Mathiesen ER, Feldt-Rasmussen B, et al. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest. 1985-1986;9(2):85\u201395.","journal-title":"Uremia Invest"},{"key":"767_CR4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1464-5491.1987.tb00905.x","volume":"4","author":"DL Cohen","year":"1987","unstructured":"Cohen DL, Close CF, Viberti GC. The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects. Diabet Med. 1987;4:437\u201340.","journal-title":"Diabet Med"},{"key":"767_CR5","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1111\/j.1440-1797.2010.01239.x","volume":"15","author":"S Chadban","year":"2010","unstructured":"Chadban S, Howell M, Twigg S, Thomas M, Jerums G, Cass A, Campbell D, Nicholls K, Tong A, Mangos G, Stack A, RJ MI, Girgis S, Colagiuri R, Colagiuri S, Craig J, CARI. The CARI guidelines. Assessment of kidney function in type 2 diabetes. Nephrology. 2010;15:S146\u201361.","journal-title":"Nephrology"},{"key":"767_CR6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2796.2003.01157.x","volume":"254","author":"CE Mogensen","year":"2003","unstructured":"Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med. 2003;254:45\u201366.","journal-title":"J Intern Med"},{"key":"767_CR7","doi-asserted-by":"crossref","unstructured":"Jerums G, M.R., Treatment of microalbuminuria in patients with type 2 diabetes mellitus. Treat Endocrinol, 2002. 1(3): p. 163-173.","DOI":"10.2165\/00024677-200201030-00004"},{"key":"767_CR8","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.2337\/diabetes.54.10.2983","volume":"54","author":"S Araki","year":"2005","unstructured":"Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, Koya D. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes. 2005;54:2983\u20137.","journal-title":"Diabetes"},{"issue":"23","key":"767_CR9","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa021835","volume":"348","author":"BA Perkins","year":"2003","unstructured":"Perkins BA, et al. Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003;348(23):2285\u201393.","journal-title":"N Engl J Med"},{"key":"767_CR10","doi-asserted-by":"crossref","unstructured":"de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD, Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study Research Group, White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the diabetes control and complications trial\/epidemiology of diabetes interventions and complications cohort. Arch Int Med. 2011;171(5):412-20.","DOI":"10.1001\/archinternmed.2011.16"},{"issue":"1","key":"767_CR11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00041552-200401000-00012","volume":"13","author":"RJ MacIsaac","year":"2004","unstructured":"MacIsaac RJ, Jerums G, Cooper ME. New insights into the significance of microalbuminuria. Curr Opin Nephrol Hypertens. 2004;13(1):83\u201391.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"Suppl 2","key":"767_CR12","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.2337\/dc11-s247","volume":"34","author":"HJ Heerspink","year":"2011","unstructured":"Heerspink HJ, et al. Monitoring kidney function and albuminuria in patients with diabetes. Diabetes Care. 2011;34(Suppl 2):S325\u20139.","journal-title":"Diabetes Care"},{"issue":"11","key":"767_CR13","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.2215\/CJN.02870316","volume":"11","author":"IH de Boer","year":"2016","unstructured":"de Boer IH, et al. Albuminuria changes and cardiovascular and renal outcomes in type 1 diabetes: the DCCT\/EDIC study. Clin J Am Soc Nephrol. 2016;11(11):1969\u201377.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"767_CR14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","volume":"60","author":"Foundation, N.K","year":"2012","unstructured":"Foundation, N.K. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60(5):850\u201386.","journal-title":"Am J Kidney Dis"},{"key":"767_CR15","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/aje\/kwh326","volume":"160","author":"AR Dyer","year":"2004","unstructured":"Dyer AR, Greenland P, Elliott P, Daviglus ML, Claeys G, Kesteloot H, Ueshima H, Stamler J, INTERMAP Research Group. Evaluation of measures of urinary albumin excretion in epidemiologic studies. Am J Epidemiol. 2004;160:1122\u201331.","journal-title":"Am J Epidemiol"},{"key":"767_CR16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/diacare.19.4.313","volume":"19","author":"M Bojestig","year":"1996","unstructured":"Bojestig M, Arnqvist HJ, Karlberg BE, Ludvigsson J. Glycemic control and prognosis in type I diabetic patients with microalbuminuria. Diabetes Care. 1996;19:313\u20137.","journal-title":"Diabetes Care"},{"key":"767_CR17","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/ndt\/16.7.1382","volume":"16","author":"GSE Dahlquist","year":"2001","unstructured":"Dahlquist GSE, Rudberg S. Urinary albumin excretion rate and glomerular filtration rate in the production of diabetic nephropathy: a long-term follow-up study of childhood onset type 1 diabetic patients. Nephrol Dialysis Transplant. 2001;16:1382\u20136.","journal-title":"Nephrol Dialysis Transplant"},{"key":"767_CR18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0009-8981(00)00414-9","volume":"304","author":"MB Gomes","year":"2001","unstructured":"Gomes MB, Gon\u00e7alves MF. Is there a physiological variability for albumin excretion rate? Study in patients with diabetes type I and non-diabetic individuals. Clin Chim Acta. 2001;304:117\u201323.","journal-title":"Clin Chim Acta"},{"key":"767_CR19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/00365518509155256","volume":"45","author":"B Feldt-Rasmussen","year":"1985","unstructured":"Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immuno assay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest. 1985;45:539\u201344.","journal-title":"Scand J Clin Lab Invest"},{"key":"767_CR20","doi-asserted-by":"crossref","unstructured":"Pugliese G, Solini A, Fondelli C, Trevisan R, Vedovato M, Nicolucci A, Penno G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group, Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency and Cardiovascular Evenets (RIACE) study. Nephrol Dial Transplant, 2011. 26: p. 3950-3954.","DOI":"10.1093\/ndt\/gfr140"},{"key":"767_CR21","unstructured":"Chadban S, Howell M, Twigg S, Thomas M, Jerums G, Cass A, Campbell D, Nicholls K, Tong A, Mangos G, Stack A, RJ MI, Girgis S, Colagiuri R, Colagiuri S, Craig J, CARI. The CARI guidelines. Prevention and management of chronic kidney disease in type 2 diabetes. Diabetes Australia NHMRC. 2009;24(3):717-8."},{"issue":"2","key":"767_CR22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1258\/acb.2009.009247","volume":"47","author":"K Kania","year":"2010","unstructured":"Kania K, et al. Urinary proteases degrade albumin: implications for measurement of albuminuria in stored samples. Ann Clin Biochem. 2010;47(2):151\u20137.","journal-title":"Ann Clin Biochem"},{"key":"767_CR23","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/diabetes.54.7.2164","volume":"54","author":"JM Steinke","year":"2005","unstructured":"Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M, International Diabetic Nephopathy Study Group. The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes. 2005;54:2164\u201371.","journal-title":"Diabetes"},{"issue":"3","key":"767_CR24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2215\/CJN.07780814","volume":"10","author":"TF Kr\u00f6pelin","year":"2015","unstructured":"Kr\u00f6pelin TF, de Zeeuw D, Andress DL, Bijlsma MJ, Persson F, Parving HH, Heerspink HJ. Number and frequency of albuminuria measurements in clinical trials in diabetic nephropathy. Clin J Am Soc Nephrol. 2015;10(3):410\u20136.","journal-title":"Clin J Am Soc Nephrol"},{"key":"767_CR25","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/clinchem\/33.11.2034","volume":"33","author":"JEA Howey","year":"1987","unstructured":"Howey JEA, Browning MC, Fraser CG. Selecting the optimum specimen for assessing slight albuminuria, and a strategy for clinical investigation: novel uses of data on biological variation. Clin Chem. 1987;33:2034\u20138.","journal-title":"Clin Chem"},{"key":"767_CR26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/bmj.306.6876.493-a","volume":"306","author":"J Johnston","year":"1993","unstructured":"Johnston J, Paterson KR, O\u2019Reilly DS. Estimating urinary albumin excretion rate of diabetic patients in clinical practice. Br Med J. 1993;306:493\u20134.","journal-title":"Br Med J"},{"issue":"9","key":"767_CR27","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1515\/CCLM.2003.188","volume":"41","author":"A Mosca","year":"2003","unstructured":"Mosca A, Paleari R, Ceriotti F, Lapolla A, Fedele D, Lercanidipine Study Group. Biological variability of albumin excretion rate and albumin-to-creatinine ratio in hypertensive type 2 diabetic patients. Clin Chem Lab Med. 2003;41(9):1229\u201333.","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"767_CR28","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2215\/CJN.09540916","volume":"11","author":"BS Dixon","year":"2016","unstructured":"Dixon BS. Is change in Albuminuria a surrogate marker for cardiovascular and renal outcomes in type 1 diabetes? Clin J Am Soc Nephrol. 2016;11(11):1921\u20133.","journal-title":"Clin J Am Soc Nephrol"},{"key":"767_CR29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2337\/diacare.12.8.585","volume":"12","author":"L Tomaselli","year":"1989","unstructured":"Tomaselli L, Trischitta V, Vinci C, Frittitta L, Squatrito S, Vigneri R. Evaluation of albumin excretion rate in overnight versus 24-h urine. Diabetes Care. 1989;12:585\u20137.","journal-title":"Diabetes Care"},{"issue":"9","key":"767_CR30","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/ndt\/gfv429","volume":"31","author":"T Felix Kropelin","year":"2016","unstructured":"Felix Kropelin T, et al. Individual long-term albuminuria exposure during angiotensin receptor blocker therapy is the optimal predictor for renal outcome. Nephrol Dial Transplant. 2016;31(9):1471\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"767_CR31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ndt\/gfp022","volume":"24","author":"WG Miller","year":"2009","unstructured":"Miller WG, Bruns DE. Laboratory issues in measuring and reporting urine albumin. Nephrol Dial Transplant. 2009;24(3):717\u20138.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0767-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T21:01:08Z","timestamp":1603486868000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0767-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["767"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0767-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"355"}}